Cargando…

Corticosteroids in severe COVID-19: a critical view of the evidence

Detalles Bibliográficos
Autores principales:	De Backer, Daniel, Azoulay, Elie, Vincent, Jean-Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595567/ https://www.ncbi.nlm.nih.gov/pubmed/33121512 http://dx.doi.org/10.1186/s13054-020-03360-0

Ejemplares similares

Critical care journals during the COVID-19 pandemic: challenges and responsibilities
por: Citerio, Giuseppe, et al.
Publicado: (2020)

Moving beyond the assessment of mortality and severity of diseases in critical patients: we are just getting started...
por: Soares, Márcio, et al.
Publicado: (2012)

A new dawn for critical care research
por: Singer, Mervyn, et al.
Publicado: (2013)

Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe Covid-19?
por: Cordeiro Veiga, Viviane, et al.
Publicado: (2022)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

Corticosteroids for non-severe COVID-19 infections? Too early to conclude
por: Park, Sunghoon
Publicado: (2023)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
por: Arabi, Yaseen M., et al.
Publicado: (2020)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

How to treat severe infections in critically ill neutropenic patients?
por: Zafrani, Lara, et al.
Publicado: (2014)

COVID-19: A rethink of corticosteroid injection?
por: Little, Christopher P., et al.
Publicado: (2020)

The fluid challenge
por: Vincent, Jean-Louis, et al.
Publicado: (2020)

High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19
por: Demoule, Alexandre, et al.
Publicado: (2020)

COVID-19 in children: patiently and critically evaluate the scientific evidence
por: Ritz, Nicole, et al.
Publicado: (2020)

A 5-point strategy for improved connection with relatives of critically ill patients with COVID-19
por: Azoulay, Elie, et al.
Publicado: (2020)

Corticosteroid Protection Against COVID-19: Begin with the Nose
por: Lipworth, Brian J., et al.
Publicado: (2021)

Two different patterns of lymphocyte alterations in critically ill COVID-19 patients
por: Lafarge, Antoine, et al.
Publicado: (2021)

Microvascular dysfunction as a cause of organ dysfunction in severe sepsis
por: Vincent, Jean-Louis, et al.
Publicado: (2005)

Corticosteroid induced avascular necrosis and COVID-19: The drug dilemma
por: Banerjee, Indrajit, et al.
Publicado: (2021)

Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19
por: Scialò, Filippo, et al.
Publicado: (2022)

Critical Care: 25th anniversary
por: Vincent, Jean-Louis
Publicado: (2022)

Clinical phenotypes of critically ill COVID-19 patients
por: Azoulay, Elie, et al.
Publicado: (2020)

Cardiac output measurements using the bioreactance technique in critically ill patients
por: Fagnoul, David, et al.
Publicado: (2012)

Guidelines in otorhinolaryngology: a critical view()
por: Fokkens, Wytske, et al.
Publicado: (2015)

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
por: Halpin, David M.G., et al.
Publicado: (2020)

Critical Care – 10 years on
por: Hubbard, Charlotte, et al.
Publicado: (2006)

The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids
por: Gonzalez-Barcala, Francisco-Javier, et al.
Publicado: (2022)

Acute kidney injury in critically ill patients with COVID-19
por: Gabarre, Paul, et al.
Publicado: (2020)

A new Critical Care channel in F1000Research
por: Vincent, Jean-Louis
Publicado: (2015)

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
por: Taccone, Fabio S, et al.
Publicado: (2020)

COVID-19: it is all about sepsis
por: Vincent, Jean-Louis
Publicado: (2021)

Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort
por: Galerneau, Louis Marie, et al.
Publicado: (2023)

A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
por: Nigro, Mattia, et al.
Publicado: (2023)

Corticosteroids for severe community-acquired pneumonia: a story without an ending
por: Rochwerg, Bram
Publicado: (2022)

Ten reasons for focusing on the care we provide for family members of critically ill patients with COVID-19
por: Azoulay, Élie, et al.
Publicado: (2020)

Taking the Longer View of COVID‐19
por: Chabner, Bruce A.
Publicado: (2020)

What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
por: Miller, Andrew C., et al.
Publicado: (2020)

ECMO during the COVID-19 pandemic: when is it unjustified?
por: Abrams, Darryl, et al.
Publicado: (2020)

Guidance production before evidence generation for critical issues: the example of COVID-19
por: Roche, Nicolas, et al.
Publicado: (2020)

How much centralization of critical care services in the era of telemedicine?
por: Ostermann, Marlies, et al.
Publicado: (2019)

Critical Care's move to fund open access
por: Slade, Elizabeth, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_8fb5knk1im4na3bjuoa4cd7od6